Reporting owner · CIK 0001755970

Finn Patrick John

Visual SEC Form 4 history across 1 companies, 14 transactions and 6 filings.

PRESPresident and COOTwist Bioscience Corp
Open-market mix
Latest filingAug 20, 2026, 08:05 PM
Filings6Form 4 records
Buying$00 purchases
Selling$9.7M11 sales
Net value−$9.7MBuys minus sells
Companies12 securities
Most recentAug 18, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1050-5-10Jan 241Jan 252Feb 251Feb 267Aug 26

Net value flow

Buys minus sells

Jan 24
$0
Jan 25
−$121.5K
Feb 25
−$221.6K
Feb 26
−$126K
Aug 26
−$9.2M

Transaction texture

Ownership and ticket size

Average P/S size$880.6K
Median P/S size$535.7K
Direct14
Indirect0
Aug 18, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern3Derivative Transactionfiling-context1Direct Ownershipfiling-context14Large Salesize5Repeat Sellerpattern810b5-1 Detectedfiling-context9

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Twist Bioscience Corp on Aug 18, 2026 valued at $245,162.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Twist Bioscience Corp on Aug 18, 2026 valued at $245,162.

Review SEC filing

Associated companies

Visual map of known reporting history

TWSTTwist Bioscience Corp14 transactions · latest Aug 20, 2026, 08:05 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
TWSTFinn Patrick John
PRES
exercise10b5-123.3k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
−3.1%08/2008/18
TWSTFinn Patrick John
PRES
sale10b5-12.00k-$24.5MS
Direct Ownership Repeat Seller 10b5-1 Detected
−3.1%08/2008/18
TWSTFinn Patrick John
PRES
sale10b5-16.29k-$76.1MS
Direct Ownership Repeat Seller 10b5-1 Detected
−3.1%08/2008/18
TWSTFinn Patrick John
PRES
sale10b5-112.9k-$154MS
Direct Ownership Large Sale Repeat Seller+1
−3.1%08/2008/18
TWSTFinn Patrick John
PRES
sale10b5-14.50k-$53.5MS
Direct Ownership Large Sale Repeat Seller+1
−3.1%08/2008/18
TWSTFinn Patrick John
PRES
sale10b5-18.86k-$104MS
Direct Ownership Large Sale Repeat Seller+1
−3.1%08/2008/18
TWSTFinn Patrick John
PRES
sale10b5-110.4k-$121MS
Direct Ownership Large Sale Repeat Seller+1
−3.1%08/2008/18
TWSTFinn Patrick John
PRES
sale10b5-133.3k-$386MS
Direct Ownership Large Sale 10b5-1 Detected
−3.1%08/2008/18
TWSTFinn Patrick John
PRES
exercise10b5-123.3k$158MM
Direct Ownership 10b5-1 Detected
−3.1%08/2008/18
TWSTFinn Patrick John
PRES
sale2.70k-$12.5MS
Cluster Selling Direct Ownership
+26.4%02/0502/03

Finn Patrick John Insider Activity FAQ

SEC Form 4 context

Who is Finn Patrick John?

Finn Patrick John is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001755970.

Which companies has Finn Patrick John reported transactions for?

Twist Bioscience Corp

When was Finn Patrick John's latest insider buy?

No open-market insider purchase is available for this period.

When was Finn Patrick John's latest insider sale?

sale at Twist Bioscience Corp on Aug 18, 2026 valued at $245,162.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.